When Monitoring Is the Active Treatment Plan

Reviewed by Dr C. J. Odike, MRCGP · June 2026

Monitoring is more than being told to keep an eye on something. It follows assessment and shared decision making. The plan needs clear measurements, review arrangements and thresholds for change.

Monitoring is active management Monitoring means collecting planned information before deciding whether the current plan should continue or change. It may involve symptoms, examination findings, blood tests, scans or function. No immediate medicine or procedure does not mean no care. Monitoring can help avoid unnecessary intervention while keeping a condition under structured review. It is appropriate only after enough assessment has been completed. It must not delay treatment or investigation that is needed now. Monitoring also needs the person's agreement. The benefits, harms, uncertainty and alternatives should be discussed through shared decision making. A practical five question model This lesson uses a practical five question teaching model. It is not a mandatory NHS checklist, and different specialties may structure decisions differently. 1. What clinical aim are we trying to achieve? 2. What options are available, including no immediate intervention? 3. What benefits, harms and burdens could each option bring? 4. What matters to this person, and can the plan work in their circumstances? 5. How will progress be measured, reviewed and acted upon? These questions apply to immediate treatment and monitoring. They also show why the right choice can differ between people with similar diagnoses. What a complete monitoring plan contains A safe plan states why monitoring is reasonable and what uncertainty remains. It identifies the feature being followed and how it will be measured. The plan includes a review interval. This is the agreed time between checks, which may change when new information appears. It identifies who orders each test, reviews the result and contacts the person. Reliable recall systems may be needed when repeated checks are planned. The plan also includes an action threshold. This is a result or change that prompts reassessment, another test or discussion about treatment. An action threshold is not always an automatic diagnosis or treatment trigger. The healthcare team usually interprets it with the wider clinical picture. Monitoring, follow up and safety netting are different Monitoring is the planned collection of information. Follow up is the arranged review where progress, results or decisions are reconsidered. Safety netting explains what to do if symptoms change before that review. A complete plan may require all three. Patient triggered contact cannot replace scheduled monitoring when progression may occur without obvious symptoms. Planned follow up cannot replace urgent reassessment when warning symptoms appear. Monitoring terms are not interchangeable Active surveillance is structured monitoring intended to detect important progression while treatment remains an available option. It often uses scheduled tests and specialist review. Watchful waiting can mean a less intensive approach in which treatment is started mainly if symptoms develop. In some conditions, it is chosen when curative treatment is unsuitable or not wanted. The terms can vary between conditions and services. Ask what the plan means in your situation rather than relying on the label alone. Monitoring has benefits and harms Monitoring may avoid or delay interventions that have side effects, recovery time or lasting effects on quality of life. It can also preserve future treatment options. However, monitoring is not risk free. It can involve anxiety, repeated appointments, invasive tests, unclear results and the possibility that important change is detected later. Missed tests or unclear responsibility can make a reasonable plan unsafe. Access, communication needs, other illnesses and personal preferences must be considered. A person may also decide that living with uncertainty is unacceptable. They can ask to review the decision before the planned date. When the plan should change Monitoring becomes unsuitable when the expected risk changes or the required follow up cannot happen reliably. New symptoms, examination findings or test changes may prompt earlier reassessment. The plan may also change because better evidence or another treatment becomes available. A person's priorities or willingness to continue monitoring may change as well. Immediate action is needed when delay could cause avoidable serious harm. Monitoring must never become a reason to postpone a time sensitive investigation or treatment. An example from prostate cancer Some people with low risk localised prostate cancer are offered active surveillance instead of immediate surgery or radiotherapy. This is a specialist led management option, not a decision to ignore cancer. The team reviews the cancer's risk features and the person's health, life expectancy and preferences. They discuss the benefits and harms of surveillance and radical treatment. The plan may include regular prostate specific antigen tests, called PSA tests, examinations and multiparametric MRI. A biopsy may be repeated when further tissue information is needed. A PSA change does not prove progression by itself. The specialist team interprets the pattern with other findings and decides whether reassessment or treatment is appropriate. NICE recommends offering active surveillance to suitable people with the lowest risk localised prostate cancer. Higher risk disease is managed differently because delay may carry greater harm. Active surveillance differs from watchful waiting. Surveillance aims to detect progression while treatment intended to cure remains possible. Radical treatment may be discussed if there is evidence of progression or if the person chooses to change the plan. The person does not need to wait for the next appointment to raise concerns. Questions you can ask Ask what is being monitored, how often and which team reviews each result. Ask what changes would prompt another test or a treatment discussion. You can also ask about the likely benefits and harms of monitoring compared with acting now. Ask what happens if an appointment or test is missed. Do not start, stop or extend a monitoring plan without clinical advice. Seek earlier help when symptoms change, worsen or cause new concern. Call 999 for life threatening symptoms. Use the urgent care route recommended for your situation when the problem cannot safely wait.

Monitoring is an active management option only when it follows adequate assessment and has a defined purpose, method, review interval, responsible team and action thresholds. It must not delay care that is needed now.

Medical words made simple

Monitoring
Planned collection and review of information to check whether a condition or management decision remains stable, improves or needs to change.
Active surveillance
Structured monitoring designed to detect important progression while treatment remains available if the situation changes.
Watchful waiting
A monitoring approach that may focus mainly on symptoms and starting treatment if problems develop. Its exact meaning depends on the condition.
Shared decision making
A person and healthcare professional working together to choose care using evidence, risks, benefits and what matters to the person.
Review interval
The agreed time between planned checks. The interval may shorten when risk or findings change.
Action threshold
A result or change that prompts reassessment, another test or discussion about changing treatment. It is not always an automatic treatment trigger.
Prostate-specific antigen (PSA)
A protein measured in blood. PSA patterns can help monitor prostate cancer, but one result does not prove progression by itself.
Multiparametric MRI
A prostate scan using several MRI techniques to assess tissue. It adds information but does not replace every other assessment.
Localised prostate cancer
Prostate cancer that appears confined to the prostate. Its risk group helps guide whether surveillance or immediate treatment is suitable.
Radical treatment
Treatment given with the intention of curing cancer, such as surgery or radiotherapy. It can have important side effects and does not guarantee cure.

Quick recap

  • Monitoring is active management when it has a defined purpose, measurements, review arrangements and responsibility.
  • The practical five question model compares aims, options, benefits, harms, personal circumstances and how the plan will be reviewed.
  • Monitoring, follow up and safety netting serve different functions, and a safe plan may require all three.
  • Active surveillance and watchful waiting are not automatically interchangeable terms.
  • Monitoring can avoid unnecessary intervention, but it can also bring burdens and a risk of delayed detection.
  • Changing findings, unreliable follow up or changing preferences should prompt reassessment rather than indefinite waiting.